We are live on
!
Find out more
FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
140 hedge funds and large institutions have $370M invested in Flexion Therapeutics, Inc. in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
69% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 36
3% less funds holding
Funds holding: 145 → 140 (-5)
12% less capital invested
Capital invested by funds: $421M → $370M (-$50.3M)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
61% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $2.64M
Holders
140
Holders Change
-5
Holders Change %
-3.45%
% of All Funds
2.44%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
19
Increased
61
Reduced
36
Closed
24
Calls
$1.04M
Puts
$2.64M
Net Calls
-$1.6M
Net Calls Change
-$886K
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$10.7M |
| 2 |
CC
Clearline Capital
New York
|
+$6.13M |
| 3 |
O
OrbiMed
New York
|
+$3.92M |
| 4 |
Morgan Stanley
New York
|
+$3.35M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.1M |
